| Literature DB >> 34924777 |
Adriana Pérez1,2, Meagan A Bluestein2, Arnold E Kuk2, Baojiang Chen1,2, Kymberle L Sterling3, Melissa B Harrell2,4.
Abstract
INTRODUCTION: Initiation of tobacco products is increasing in young adulthood. This study prospectively estimated the age of onset of susceptibility to cigarettes, e-cigarettes, hookah, smokeless tobacco, and cigarillos among young adults, which is a cognitive precursor to initiation.Entities:
Keywords: cigarettes; cigarillos; e-cigarettes; hookah; smokeless tobacco; survival analysis
Year: 2021 PMID: 34924777 PMCID: PMC8671673 DOI: 10.1177/1179173X211065643
Source DB: PubMed Journal: Tob Use Insights ISSN: 1179-173X
Demographic characteristics of PATH¥ USA young adults non-susceptible to each tobacco product at waves 2 or 3 (2014-2016).
| Total | Cigarettes | E-cigarettes | Hookah | Smokeless tobacco | Cigarillos | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| n = 2989; | n = 2671; | n = 3108; | n = 7190; | n = 3356; | |||||||
| n; N | %* | n; N | %* | n; N | %* | n; N | %* | n; N | %* | ||
|
| Wave 1 young adult | 1442; 6 640 206 | 66.1% (.83) | 1395; 6 408 648 | 69.7% (.78) | 1520; 7 003 857 | 66.9% (.80) | 4348; 15 684 808 | 71.6% (.36) | 2290; 12 008 870 | 83.5% (.44) |
| Wave 2 young adult | 776; 1 734 233 | 17.3% (.57) | 618; 1 368 121 | 14.9% (.52) | 731; 1 618 695 | 15.5% (.54) | 1452; 3 214 060 | 14.7% (.29) | 1066; 2 367 837 | 16.5% (.44) | |
| Wave 3 young adult | 771; 1 665 171 | 16.6% (.53) | 658; 1 417 927 | 15.4% (.57) | 857; 1 832 503 | 17.5% (.56) | 1390; 3 006 307 | 13.7% (.26) | N/A | ||
|
| Weighted mean (SE) | 19.6 (.05) | 19.6 (.04) | 19.7 (.04) | 19.8 (.02) | 20.9 (.04) | |||||
|
| Male | 1317; 4 549 974 | 45.4% (1.01) | 1148; 4 065 548 | 44.2% (1.01) | 1539; 5 213 376 | 49.9% (.90) | 2991; 9 378 994 | 42.8% (.38) | 1332; 5 891 065 | 41.0% (.8) |
| Female | 1669; 5 481 426 | 54.6% (1.01) | 1521; 5 123 014 | 55.7% (1.01) | 1566; 5 233 469 | 50.1% (.90) | 4197; 12 522 135 | 57.2% (.38) | 2018; 8 463 353 | 59.0% (.8) | |
| Missing | n = 3; N = 8211 | n = 2; N = 6134 | n = 3; N = 8210 | n = 2; N = 4046 | n = 6; 22 288 | ||||||
|
| Non-Hispanic White | 1397; 5 223 857 | 52.0% (1.49) | 1289; 4 992 430 | 54.3% (1.7) | 1578; 5 855 265 | 56.0% (1.55) | 3240; 11 073 692 | 50.6% (.82) | 1617; 7 544 182 | 52.5% (1.4) |
| Hispanic | 714; 1 905 249 | 19.0% (1.00) | 632; 1 706 625 | 18.6% (1.09) | 733; 1 969 468 | 18.8% (.93) | 1972; 4 910 338 | 22.4% (.59) | 920; 3 134 540 | 21.8% (.95) | |
| Non-Hispanic Black | 596; 1 771 230 | 17.6% (.85) | 509; 1 503 797 | 16.4% (1.01) | 522; 1 555 169 | 14.9% (.93) | 1300; 3 543 914 | 16.2% (.49) | 484; 1 827 227 | 12.7% (.7) | |
| Non-Hispanic other | 282; 1 139 273 | 11.3% (1.03) | 241; 991 844 | 10.8% (1.17) | 275; 1 075 152 | 10.3% (1.07) | 678; 2 377 230 | 10.9% (.62) | 334; 1 868 349 | 13.0% (1.1) | |
| Missing | 0 | 0 | 0 | 0 | n = 1; N = 2408 | ||||||
|
| 0 tobacco products | 2047; 7 541 603 | 75.1% (1.19) | 1832; 6 657 864 | 72.2% (1.25) | 2006; 7 406 439 | 70.8% (1.30) | 2708; 10 132 556 | 46.3% (1.08) | 1716; 8 400 420 | 58.4% (1.41) |
| 1 tobacco product | 560; 1 506 984 | 15.0% (.81) | 415; 1 352 983 | 14.9% (.86) | 450; 1 391 132 | 13.3% (.80) | 1170; 3 420 488 | 15.6% (.53) | 596; 2 468 010 | 17.2% (.94) | |
| 2+ tobacco products | 382; 991 022 | 9.9% (.70) | 381; 1 079 905 | 11.9% (.80) | 652; 1 657 484 | 15.9% (.88) | 3312; 8 352 132 | 38.1% (.94) | 1044; 3 508 277 | 24.4% | |
| Missing | 0 | n = 43; N = 103 945 | 0 | 0 | 0 | ||||||
¥ PATH restricted file received disclosure to publish: April 6, 2021. United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse, and United States Department of Health and Human Services. Food and Drug Administration. Center for Tobacco Products. Population Assessment of Tobacco and Health (PATH) Study [United States] Restricted-Use Files. ICPSR36231-v13. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], November 5, 2019. https://doi.org/10.3886/ICPSR36231.v23
*All percentages represent weighted percentages based on PATH’s complex sampling design; N/A: not available.
Estimated hazard functions* (95% confidence intervals) of the age of onset of susceptibility to each tobacco product for PATH¥ USA young adults (aged 18-24).
| Age | Weighted percentage of susceptibility onset to each tobacco product by age | ||||
|---|---|---|---|---|---|
| Cigarettes | E-cigarettes | Hookah | Smokeless tobacco | Cigarillos | |
|
| 0 | 0 | 0 | 0 | 0 |
|
| 7.2 (6.2-8.2) | 6.7 (2.1-11.3) | 8.6 (7.6-9.6) | 3.0 (2.6-3.4) | 5.7 (5.0-6.5) |
|
| 10.1 (4.9-15.4) | 11.1 (6.5-15.6) | 12.8 (9.7-15.9) | 4.0 (2.4-5.5) | 8.8 (7.5-10.1) |
|
| 12.4 (8.6-16.1) | 16.0 (11.5-20.6) | 16.5 (14.9-18.2) | 5.9 (3.9-7.9) | 12.6 (10.9-14.4) |
|
| 16.8 (14.0-19.6) | 21.1 (16.3-25.9) | 20.2 (18.0-22.3) | 8.3 (7.2-9.4) | 18.0 (15.5-20.4) |
|
| 19.4 (12.1-26.7) | 25.9 (17.4-34.3) | 26.2 (15.6-36.7) | 11.3 (9.7-12.8) | 26.4 (22.7- 30.2) |
|
| 23.7 (20.6-26.7) | 29.4 (24.0-34.8) | 26.6 (23.9-29.4) | 11.5 (10.2-12.8) | N/A |
*Hazard functions are reported as cumulative percentages (i.e., cumulative incidence).
N/A: not enough sample size to estimate onset of susceptibility at that age.
¥ PATH restricted file received disclosure to publish: July 24, 2020; July 15, 2020; September 28, 2020. United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse, and United States Department of Health and Human Services. Food and Drug Administration. Center for Tobacco Products. Population Assessment of Tobacco and Health (PATH) Study [United States] Restricted-Use Files. ICPSR36231-v13. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], November 5, 2019. https://doi.org/10.3886/ICPSR36231.v23
Figure 1.The age of onset of susceptibility to each tobacco product.
Crude and adjusted hazard ratios (95% confidence intervals) for age of onset of susceptibility to each tobacco product among PATH¥ USA young adults (aged 18-24).
| Product | Crude hazard ratios for age of susceptibility onset | ||||
|---|---|---|---|---|---|
| Cigarettes | E-cigarettes | Hookah | Smokeless tobacco | Cigarillos | |
| Sex | |||||
| Female | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Male | 1.09 (.89-1.34) | 1.03 (.84-1.26) | .98 (.80-1.19) |
| 1.21 (.98-1.5) |
|
| |||||
| Non-Hispanic White | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Hispanic |
| 1.36 (1.00-1.84) | 1.22 (.95-1.56) |
| 1.23 (.93-1.63) |
| Non-Hispanic Black | 1.28 (.98-1.69) | 1.04 (.76-1.43) |
| .93 (.68-1.25) |
|
| Non-Hispanic other* | 1.31 (.89-1.93) |
| 1.21 (.79-1.83) | .88 (.59-1.32) | .72 (.47-1.12) |
|
| |||||
| 0 Tobacco products | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| 1 Tobacco product |
| 1.12 (.87-1.46) |
|
|
|
| 2+ Tobacco products |
| 1.03 (.79-1.35) |
|
|
|
|
| |||||
|
|
|
|
|
|
|
| |
| ||||
| Female | 1.00 | 1.00 | 1.00 | 1.00 |
|
| Male | 1.09 (.88-1.35) | 1.00 (.82-1.23) | .95 (.78-1.17) |
|
|
| |
| ||||
| Non-Hispanic White | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Hispanic |
| 1.35 (.99-1.83) | 1.25 (.99-1.59) |
| 1.14 (.86-1.50) |
| Non-Hispanic Black | 1.28 (.97-1.70) | 1.05 (.76-1.45) |
| .91 (.68-1.22) |
|
| Non-Hispanic other* | 1.36 (.92-2.01) |
| 1.34 (.89-2.02) | .88 (.59-1.31) | .75 (.49-1.14) |
|
| |||||
| 0 Tobacco products | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| 1 Tobacco product |
| .98 (.74-1.29) |
|
|
|
| 2+ Tobacco products |
| .99 (.76-1.31) |
|
|
|
¥ PATH restricted file received disclosure to publish: July 15 and 24, 2020, and April 6, 2021. United States
Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse, and United States Department of Health and Human Services. Food and Drug Administration. Center for Tobacco Products. Population Assessment of Tobacco and Health (PATH) Study [United States] Restricted-Use Files. ICPSR36231-v13.Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], November 5, 2019. https://doi.org/10.3886/ICPSR36231.v23
*Non-Hispanic other includes Asian, multiracial, etc.
Estimated hazard functions* (95% confidence interval) for the age of onset of susceptibility by sex among PATH¥ USA young adults (aged 18-24).
| Age | Age of onset of susceptibility | |||
|---|---|---|---|---|
| Male | Female | Male | Female | |
| Smokeless tobacco | Cigarillos | |||
|
| 0.0 | 0.0 | 0.0 | 0.0 |
|
| 3.9 (3.2-4.5) | 2.4 (1.9-2.9) | 6.6 (5.1-8.0) | 5.2 (4.3-6.1) |
|
| 4.2 (2.4-6.0) | 3.2 (1.6-4.8) | 9.4 (7.4-11.3) | 8.2 (6.7-9.7) |
|
| 8.1 (6.8-9.5) | 4.3 (3.2-5.3) | 13.8 (11.3-19.3) | 11.7 (9.6-13.8) |
|
| 11.7 (10.1-13.2) | 4.3 (3.4-5.1) | 20.9 (17.0-24.7) | 15.8 (12.7-18.9) |
|
| 14.0 (9.2-18.8) | 8.5 (6.4-10.6) | 30.1 (24.2-36.1) | 23.8 (19.2-28.4) |
|
| 15.2 (13.2-17.2) | 8.7 (7.2-10.2) | N/A | N/A |
*Hazard functions are reported as cumulative percentages (i.e., cumulative incidence).
N/A: not enough sample size to estimate onset of susceptibility at that age.
¥ PATH restricted file received disclosure to publish: July 24, 2020, and July 15, 2020. United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse, and United States Department of Health and Human Services. Food and Drug Administration. Center for Tobacco Products. Population Assessment of Tobacco and Health (PATH) Study [United States] Restricted-Use Files. ICPSR36231-v13. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], November 5, 2019. https://doi.org/10.3886/ICPSR36231.v23
Figure 2.The age of onset of susceptibility stratified by sex.
Estimated hazard functions (95% confidence intervals) for the age of onset of susceptibility to each tobacco product by race/ethnicity among PATH¥ USA young adults (aged 18-24).
| Age | Non-Hispanic White | Hispanic | Non-Hispanic Black | Non-Hispanic other† |
|---|---|---|---|---|
|
| ||||
| 18 | .0% | .0% | .0% | .0% |
|
| 6.0 (4.7, 7.2) | 9.7 (5.5, 13.9) | 8.1 (5.7, 10.5) | 2.9 (.7, 5.1) |
|
| 7.4 (4.3, 10.4) | 13.8 (5.2, 22.4) | 11.8 (8.9, 14.6) | 10.0 (5.1, 15.0) |
|
| 11.0 (5.3, 16.6) | 16.7 (11.1, 22.3) | 12.9 (9.0, 16.8) | 11.2 (6.1, 16.4) |
|
| 14.4 (7.4, 21.3) | 16.7 (12.2, 21.3)e | 18.6 (14.4, 22.8) | 16.3 (4.4, 28.2) |
|
| 14.4 (12.0, 16.8) | 21.2 (15.7, 26.6) | 18.6 (14.4, 22.8) | 27.8 (18.1, 37.4) |
|
| 21.7 (16.8, 26.5) | 27.8 (21.1, 34.6) | 24.3 (18.8, 29.7) | 29.2 (19.2, 39.2) |
|
| ||||
| | .0% | .0% | .0% | .0% |
| | 7.6% (5.1-10.2) | 4.2% (1.9-6.4) | 5.2% (.0-10.3) | 13.8% (.6-27.0) |
| | 11.9% (9.5-14.3) | 10.8% (6.7-14.9) | 12.1% (4.8-19.4) | 15.1% (7.3-23.0) |
| | 15.9% (13.1-18.8) | 24.5% (18.8-30.2) | 16.2% (8.6-23.7) | 21.7% (11.2-32.3) |
| | 20.4% (14.8-25.9) | 29.0% (21.2-36.8) | 19.5% (14.7-24.2) | 32.4% (16.3-48.5) |
| | 25.5% (15.2-35.9) | 29.0% (22.6-35.4) | 19.5% (14.8-24.2) | 38.2% (24.6-51.8) |
| | 28.8% (23.7-34.0) | 37.8% (29.1-46.6) | 32.8% (23.6-42.1) | 39.8% (26.3-53.4) |
|
| ||||
| | .0% | .0% | .0% | .0% |
| | 7.8 (6.4-9.2) | 9.6 (7.5-11.7) | 6.1 (1.0-11.3) | 10.9 (1.2-20.7) |
| | 9.8 (5.4-14.2) | 15.0 (4.5-25.5) | 14.9 (11.2-18.5) | 13.6 (7.3-19.8) |
| | 14.8 (12.8-16.9) | 17.5 (11.0-24.1) | 14.9 (11.4-18.4) | 18.4 (11.1-25.6) |
| | 14.8 (12.8-16.9) | 23.5 (17.9-29.1) | 27.5 (22.3-32.6) | 21.8 (12.1-31.5) |
| | 23.8 (15.0-32.5) | 27.7 (21.9-33.5)τ | 27.5 (22.5- 32.4)h | 29.2 (17.9-40.5) |
| | 23.8 (20.3-27.2) | 27.7 (21.4-33.9) | 34.4 (28.2-40.7) | 29.2 (18.7-39.7) |
| | .0% | .0% | .0% | .0% |
| | 2.8 (2.2-3.3) | 4.2 (3.2-5.2) | 2.2 (1.3-3.1) | 1.1 (.2-2.1) |
| | 3.5 (1.8-5.2) | 6.1 (2.7-9.5) | 3.2 (2.1-4.4) | 4.0 (1.5-6.4)Ψ |
| | 5.0 (3.5-6.5) | 9.6 (3.1-16.0) | 4.3 (2.5-6.2) | 5.1 (2.8-7.4) |
| | 6.6 (3.3-10.0) | 13.0 (10.5-15.5) | 6.2 (2.9-9.4) | 7.3 (3.0-11.6) |
| | 10.5 (7.7-13.2) | 15.4 (9.8-21.0) | 7.2 (5.3-9.2) | 9.0 (5.6-12.5) |
| | 10.6 (8.7-12.5) | 15.9 (12.9-18.9) | 10.2 (7.4-12.8) | N/A |
|
| ||||
| | .0% | .0% | .0% | .0% |
| | 5.3 (4.1-6.4) | 7.0 (5.1-8.9) | 9.3 (6.3-12.2) | 2.2 (.5-4.0) |
| | 8.0 (6.3-9.8) | 11.1 (8.5-13.6) | 11.8 (8.0-15.5) | 5.4 (1.5-9.4) |
| | 12.4 (9.9-14.9) | 14.4 (10.9-17.8) | 14.9 (10.6-19.3) | 8.2 (3.7-12.7) |
| | 16.8 (13.6-20.1) | 21.6 (16.7-26.5) | 21.5 (15.8-27.2) | 13.5 (6.9-20.1) |
| | 26.0 (20.7-31.2) | 29.8 (23.3-36.2) | 29.4 (19.9-38.8) | 21.0 (12.4-29.6)Ξ |
| | N/A | N/A | N/A | N/A |
aHazard functions are reported as cumulative percentages (i.e., cumulative incidence).
¥ PATH restricted file received disclosure to publish: July 15 and 24, 2020, and April 6, 2021. United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse, and United States Department of Health and Human Services. Food and Drug Administration. Center for Tobacco Products. Population Assessment of Tobacco and Health (PATH) Study [United States] Restricted-Use Files. ICPSR36231-v13. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], November 5, 2019. https://doi.org/10.3886/ICPSR36231.v23
† Non-Hispanic other includes Asian, multiracial, etc
e interval represents 22 years and 16 weeks
τ interval represents 23 years and 18 weeks
h interval represents 23 years and 22 weeks
Ψ interval represents 20 years and 13 weeks
Ξ interval represents 23 years and 22 weeks
N/A: not enough sample size to estimate onset of susceptibility at that age.
Figure 3.The age of onset of susceptibility stratified by race/ethnicity.